Humanigen has spent over $150 million on manufacturing lenzilumab over the last year and its market cap is only $132 million.
Why would anyone compare the amount they spent on manufacturing to market cap? Next you'll compare the amount of money they spent on flights to investor presentations or toilet paper on the c-suite to market cap. Come on man!!
Good data will send the share price skyrocketing. A day with over 1000% gains to the share price is realistic.
Realistic? Haha... Come on man!! You've clearly been hanging around with CJ too long.
It is an incredibly opportune time to get back into HGEN.
You should probably just sit this one out, given you started saying this when HGEN was in the 6's... Your wonderful advice has led to 60+% losses for anyone dumb enough to listen.
Make it so. You convinced me but I'm fully invested. Wish I had bought in at this price point. But will have very little regret if the upcoming data supports LENZ's effectiveness and vast possibilities.